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Abstract
Background: Throughout Asia, people who use drugs are confined in facilities referred to as compulsory drug detention
and rehabilitation centers. The limited transparency and accessibility of these centers has posed a significant challenge to
evaluating detainees and detention conditions directly. Despite HIV being highly prevalent in this type of confined setting,
direct evaluation of detainees with HIV and their access to medical care has yet to be reported in the literature.
Methods: We evaluated the health status of 100 adult male detainees with HIV and their access to medical care in the two
largest Malaysian compulsory drug detention and rehabilitation centers holding HIV-infected individuals.
Results: Approximately 80% of all detainees with HIV were surveyed in each detention center. Most participants reported
multiple untreated medical conditions. None reported being able to access antiretroviral therapy during detention and only
9% reported receiving any HIV-related clinical assessment or care. Nearly a quarter screened positive for symptoms
indicative of active tuberculosis, yet none reported having been evaluated for tuberculosis. Although 95% of participants
met criteria for opioid dependence prior to detention, none reported being able to access opioid substitution therapy
during detention, with 86% reporting current cravings for opioids and 87% anticipating relapsing to drug use after release.
Fourteen percent of participants reported suicidal ideation over the previous two weeks.
Conclusion: We identified a lack of access to antiretroviral therapy in two of the six compulsory drug detention and
rehabilitation centers in Malaysia designated to hold HIV-infected individuals and found significant, unmet health needs
among detainees with HIV. Individuals confined under such conditions are placed at considerably high risk for morbidity
and mortality. Our findings underscore the urgent need for evidence-based drug policies that respect the rights of people
who use drugs and seek to improve, rather than undermine, their health.
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Introduction
Throughout Asia, people who use drugs are confined and forced
to undergo drug rehabilitation in specialized facilities referred to as
compulsory drug detention and rehabilitation centers [1,2]. These
centers are operated by government agencies, although the specific
supervising body differs by country [3]. In Malaysia, they are
operated by the National Anti-Drug Agency (AADK). Despite
their intended purpose of drug rehabilitation, these centers are
custodial and managed primarily by military or security personnel
[3,4]. Over the last decade, compulsory drug detention and
rehabilitation centers have grown exponentially throughout East
and Southeast Asia [4] and currently detain over an estimated
400,000 individuals each year [5]. In 2010, an estimated 6,658
individuals were detained across Malaysia’s 28 compulsory drug
rehabilitation centers.
Grounds for detention in these centers range from having a
positive urine drug screen to being suspected of illicit drug use
[3,6]. Individuals are routinely denied due process and, in some
cases, may be detained indefinitely [3,6–8]. Under Malaysia’s drug
control laws, any individual with a positive urine screening for
substances classified as illicit by the Dangerous Drug Act (1952)
and the Drug Dependence (Treatment and Rehabilitation) Act
(1983) and deemed to be drug-dependent by a government
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medical officer can be mandated to two years of detention and two
years of community supervision following release [9]. Evidence-
based therapies for substance use disorders, such as opioid
substitution therapy, are typically not provided during detention.
Instead, compulsory abstinence, military drills, and other ap-
proaches with unproven efficacy are utilized as rehabilitation
measures [3,7,10]. In some countries, detainees may also be
subjected to forced labor and physical abuse [3,4,7,10]. Given
these practices, drug-related outcomes are often poor after release,
with an estimated 70–90% of those leaving Malaysian compulsory
drug detention and rehabilitation centers relapsing to drug use
within one year of release [11] and similarly high relapse rates
reported across Asia [3,4].
HIV prevalence is reported to be extremely high in these
centers [12,13]. In Malaysia, where people who inject drugs
account for two-thirds of all HIV infections [11], HIV prevalence
in compulsory drug detention and rehabilitation centers is
estimated to be 10%, nearly two-fold higher than in prisons and
20-fold higher than in the community [14]. Less is known,
however, about the provision of HIV treatment and care for
detainees. Across Asia, human rights agencies have repeatedly
identified limited to no access to antiretroviral therapy in
compulsory drug detention and rehabilitation centers based on
interviews with former detainees and personnel from non-
governmental organizations, and different studies have reported
poor, non-HIV related health outcomes among both current and
former detainees [2–4,7,8,10,15–18].
Despite HIV being highly prevalent in this type of confined
setting, direct evaluation of detainees with HIV and their access to
medical care has yet to be reported in the peer-reviewed literature.
The limited transparency and accessibility of these centers has
challenged efforts to evaluate detainees and detention conditions
directly [12,13,19,20]. In Malaysia, first-line antiretroviral therapy
is fully subsidized, yet, it remains unknown whether this treatment
policy is upheld in compulsory drug detention and rehabilitation
centers. Interviewing current detainees would provide much-
needed information on their health and well-being and further
illuminate the conditions inside these settings. We obtained access
to the two largest Malaysian compulsory drug detention and
rehabilitation centers holding HIV-infected individuals and
evaluated the health status of detainees with HIV and their access
to medical care during confinement.
Methods
Ethics Statement
The Medical Ethics Committee of the University Malaya
Medical Centre approved all aspects of the study and the use of
oral informed consent. Oral informed consent was obtained from
study participants as the only record linking the participant and
the research would have been the consent document and we
determined that the principal risk would be the potential harm
resulting from any breaches of confidentiality. The oral informed
consent process was documented by providing individuals with a
form outlining the purpose and procedures of the study and a
consent statement that individuals only needed to check ‘yes’ or
‘no’ to. This form was also dated and initialed by study
interviewers.
Based on the national drug agency’s memorandums of
agreement with the Ministry of Health, HIV-infected detainees
are placed in one of six compulsory drug detention and
rehabilitation centers where HIV treatment and care is designated
to be accessible. From July to August 2010, 100 HIV-infected
adult males were surveyed in the two largest compulsory drug
detention and rehabilitation centers housing HIV-infected detain-
ees. Both sites were male-only facilities (there is only one facility in
the country that houses women) and were located in Peninsular
Malaysia. One facility was located in Besut, Terengganu in the
northeast (387 detainees; 54 detainees were HIV-infected) and the
other was located in Muar, Johor in the south (407 detainees; 70
detainees were HIV-infected). In each detention facility, HIV
testing is mandatory and detainees with confirmed HIV infection
are housed separately, involuntarily disclosing their HIV status
both to other detainees and to facility staff.
A 90-minute survey was administered that assessed previous
involvement with the criminal justice system and compulsory drug
detention and rehabilitation centers, drug use prior to detention,
self-reported HIV-related symptoms, and access to medical
treatment and care and contained validated clinical assessments
for opioid dependence (MINI) [21], addiction severity (DAST-10)
[22], depression (PHQ-9) [23], and a tuberculosis (TB) symptom
screening algorithm for individuals with HIV infection [24]. The
MINI and DAST-10 and the TB symptom screening algorithm
have not been validated in Malaysia but have previously been
validated in other Southeast Asian countries. The PHQ-9 has
been used in previous studies in Malaysia but has not been
formally validated. The survey instrument was translated from
English to Bahasa Malaysia and back-translated to English using
previously described methods [25]. Surveys were piloted in Bahasa
Malaysia with former drug users and further adapted for linguistic
precision and socio-cultural sensitivity.
Researchers were allowed 10 days at each facility for study
recruitment. There were no incentives or disincentives for study
participation. All HIV-infected detainees at each facility were
eligible and notified of the study by trained research assistants
fluent in Bahasa Malaysia who visited the segregation units where
HIV-infected individuals were housed to describe the study.
Individuals expressing interest were escorted by research assistants
to confidential interview rooms and taken through an oral
informed consent process. Those who agreed to participate in
the study provided oral informed consent and were subsequently
recruited into the study and surveyed. Study participation was
anonymous and no personal identifiers were collected. After data
collection was completed, an educational session on HIV
treatment and care was provided to all HIV-infected detainees,
irrespective of study participation, and to the counselors assigned
to address their needs.
Data were analyzed with SPSS 16 (SPSS, Inc., Chicago IL)
using Chi-square and Student t-tests. P-values,0.05 were
considered statistically significant.
Results
Mandated duties, including work, counseling, required exercis-
es, and religious sessions did not allow for all eligible and willing
subjects to be recruited during the interview periods. By the end of
each survey period, however, 44 (81.5%) of all 54 eligible detainees
in Besut and 56 (80%) of all 70 eligible detainees in Muar had been
surveyed. Of the 107 eligible individuals interested in participating
in the study, six were deemed too ill to complete the survey and
one declined participation after learning more details about the
study.
Participant characteristics are summarized in Table 1. There
were no significant differences between participants from the two
sites with regard to demographic characteristics, health status and
access to care (data not shown). Both detention centers reported
relying on external medical facilities, primarily government district
hospitals, for acute care of HIV-infected detainees, although it was
Risk Factors for Morbidity and Mortality
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unclear who makes referrals for detainees to be brought to external
facilities for care. Aside from a medical assistant in one facility who
was trained to address non-urgent medical issues, comprehensive
on-site medical services and routine access to medical care were
not available at either facility. Most individuals (91%) surveyed
were Malay, 70% reported being from a rural area (kampung).
Participants reported a mean of 3.0 and 2.3 cumulative detentions
in prison and compulsory drug detention and rehabilitation
centers, respectively. Most detainees (78%) had been diagnosed
with HIV in a confined setting, with 20% reporting being
diagnosed during this detention.
Substance use disorders were highly prevalent among partici-
pants, with 95% meeting DSM-IV criteria for opioid dependence
prior to detention and 93% reporting substantial or high addiction
severity prior to detention. None reported being offered opioid
substitution therapy during confinement. Table 2 describes
participants’ pre-detention drug use. Heroin was the most
commonly cited (94%) drug of choice. However, daily use of
multiple substances in the 30 days prior to detention was reported
by 40% of participants. Drug injection in the 30 days prior to
detention was reported by 95% of subjects, with 65% reporting
daily heroin injection and 22% reporting daily injection of
multiple substances. Despite being detained for a mean of 7.5
months (Table 1), 86% of participants reported having current
cravings for opioids and 58% reported current cravings for
methamphetamines. Eighty-seven percent of participants reported
anticipating relapsing to drug use after release. Prior experience
with medication-assisted treatment was limited, with only 24%
reporting previous treatment with methadone and 15% with
buprenorphine.
The mean time since HIV diagnosis among participants was 5.4
years, yet none reported being able to access antiretroviral therapy
during detention and only 9% reported receiving any HIV-related
clinical assessment or care. Sixty-nine percent of participants
believed their HIV infection had become symptomatic. Addition-
ally, 74% of participants reported that since their diagnosis, they
had not received any further HIV-related clinical assessment or
care. While 97% of participants reported wanting to know their
current CD4 lymphocyte count, only 34% had ever been CD4
tested and only 18% had ever received a CD4 test result. Of those
Table 1. Participant Characteristics (n = 100).*
Age in years, mean (SD) 35.0 (6.5)
Ethnicity
Malay 91
Chinese 4
Indian 5
Married 23
Completed high school 33
Monthly income below poverty level 15
Religion
Muslim 92
Other 8
Place of residence prior to detention
Rural 70
Urban or suburban 30
Unstable housing prior to detention 11
Detention history
Jail incarcerations, mean (SD) 7.6 (5.8)
Prison incarcerations, mean (SD) 3.0 (2.9)
Lifetime number of months incarcerated in a jail or prison, mean (SD) 35.6 (44)
Detentions in compulsory drug detention and rehabilitation facilities, mean (SD) 2.3 (1.7)
Lifetime number of months detained in a compulsory drug detention and rehabilitation facility, mean (SD) 22.0 (21.1)
Age at first incarceration in jail or prison, mean (SD) 27.6 (7.1)
Age at first detention in a compulsory drug detention and rehabilitation facility, mean (SD) 21.9 (5.7)
Months since entry into the compulsory drug detention and rehabilitation facility, mean (SD) 7.5 (3.2)
Location of HIV diagnosis
Compulsory drug detention and rehabilitation facility 41
Jail or prison 40
Hospital or ambulatory clinic 19
Received HIV diagnosis during current detention 20
Never been HIV tested prior to diagnosis 59
Months since HIV diagnosis, mean (SD) 64.8 (55.7)
*Where mean (SD) is not indicated, results presented represent both n and % as 100 participants answered all questions resulting in no missing data.
doi:10.1371/journal.pone.0044249.t001
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who had ever received a CD4 test result (n = 18), the median CD4
count was 315 cells/mL (range 15–1025 cells/mL). However, 61%
of these reported CD4 test results were from over two years ago.
Although 14% of participants had previously been recommended
by a medical professional to initiate antiretroviral therapy, only
four participants had ever done so. Three of these four participants
reported they were on antiretroviral therapy in the 30 days prior to
detention and were forced to discontinue treatment due to its
unavailability in the detention facility. The vast majority (87%) of
participants reported wanting to access HIV care after their
release.
Twenty-three percent of participants screened positive for
symptoms indicative of active tuberculosis based on a screening
algorithm (sensitivity 93%; specificity 36%) using three indicators,
prolonged cough (65%), fever (56%) and night sweats (30%) for
$3 weeks in the preceding month [24]. However, none of these
individuals reported having received any assessment for tubercu-
losis during confinement. Fourteen percent of participants
reported suicidal ideation over the previous two weeks.
Discussion
We identified a lack of access to antiretroviral therapy in two of
the six Malaysian compulsory drug detention and rehabilitation
centers holding HIV-infected individuals and found significant,
unmet health needs among detainees with HIV. Most of our
participants reported multiple, untreated and potentially life-
threatening medical conditions. Despite antiretroviral therapy
being fully government-subsidized, none of our participants
reported being able to access antiretroviral therapy during
detention, including those who were on therapy prior to detention.
Few participants reported receiving any HIV-related clinical
assessment or care, and none of the 23 individuals screening
positive for symptoms indicative of active tuberculosis reported
being clinically evaluated. A quarter of participants reported
recent suicidal ideation and nearly all participants met criteria for
opioid dependence prior to detention and anticipated relapsing to
drug use after release. It is clear from these findings that
individuals are being confined under conditions that place them
at considerably high risk for morbidity and mortality, both during
detention and after release.
We surveyed only 80% of all eligible individuals, potentially
introducing selection bias. However, even if those who had not
been surveyed reported better outcomes, our findings would
remain concerning in both magnitude and severity. Our study also
only evaluated compulsory drug detention and rehabilitation
centers in Malaysia and thus is limited in its generalizability.
Despite these important limitations, our findings provide further
evidence of life-threatening conditions in this type of confined
setting. Increasingly, many international agencies and actors,
including UNAIDS, UNODC, UNDP, UNICEF, the WHO, the
Global Fund to Fight AIDS, Tuberculosis and Malaria, and the
UN High Commissioner for Human Rights have called for the
closing of compulsory drug rehabilitation and detention centers
and the implementation of evidence-based drug policies that
recognize the rights of people who use drugs [26].
Beginning in 2010, the national drug agency in Malaysia began
closing compulsory drug detention and rehabilitation centers
throughout the country and converting the physical spaces into
voluntary drug treatment centers. These new voluntary treatment
centers offer access to fully-subsidized methadone maintenance
therapy and other health and social services [27]. Thus far, 10 of
the 28 national detention centers have been closed. Examination
of this ongoing policy transition is needed and findings related to
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its impact and cost-effectiveness may provide further support for
this transition in Malaysia and may potentially galvanize similar
policy change in other countries. In particular, the newly opened
voluntary treatment centers and their acceptability among people
who use drugs must be closely evaluated given their former status
as detention centers. Evaluation efforts can identify potential
strengths of the new system as well as areas in which service
delivery and accessibility can be improved to meet the needs of
those seeking care.
Access to opioid substitution therapy, an essential medicine and
key HIV prevention modality, will be vastly expanded if the
national drug agency completes this transition to a voluntary,
treatment-based system. Conversely, even with this policy shift,
people who use drugs will continue to confront significant barriers
to accessing treatment and care for HIV. While none of the
participants in our study were able to access antiretroviral therapy
during confinement, their access in the community was similarly
limited. Despite first-line antiretroviral therapy being fully
subsidized, only four participants reported ever being on
antiretroviral therapy, only a quarter of participants reported
receiving any further HIV-related clinical assessment or care since
their diagnosis, and only 18 participants reported ever receiving a
CD4 test result. In Malaysia as well as across Asia, people who use
drugs face especially limited access to HIV treatment and care due
to stigma, discrimination and criminalization [2,28–30]. These
treatment barriers have serious implications for their health, well-
being and survival but, thus far, have not garnered the requisite
attention or mobilization. Given the additional prevention benefit
of antiretroviral therapy, these treatment barriers also significantly
hamper HIV prevention efforts and overall efforts to address the
rapidly growing regional epidemic.
Targeted efforts to improve access to HIV treatment and care
for this population have yet to be engaged in Malaysia and are
urgently needed. These efforts should be rooted in community-
based strategies, such as engaging outreach workers in needle and
syringe exchange programs in HIV testing and linkage to care and
actively integrating and co-locating treatment services for HIV,
TB, hepatitis C and substance use disorders in drug treatment
centers. Needle and syringe exchange programs and drug
treatment centers are the primary points of access to people who
use drugs throughout the country, but these settings have yet to be
utilized in delivering other critical health services to this
population, such as voluntary HIV testing and provision of or
linkage to HIV treatment and care. While HIV testing typically
serves as the gateway for entry into care, the vast majority of our
participants were first diagnosed with HIV in a prison or
compulsory drug detention and rehabilitation facility. Confined
settings where HIV testing is mandatory, individuals testing
positive are segregated, and treatment and care are largely
unavailable [31] should not be the primary contexts in which
people who use drugs are being tested for HIV. The rest of our
participants (20%) reported receiving their first positive HIV test
result in a hospital or ambulatory clinic, with no other settings
reported. Given the marginalization of people who use drugs,
voluntary HIV testing venues outside of traditional healthcare
settings would likely be far more effective in reaching this
population. Our findings highlight the importance of expanding
community-based, voluntary HIV testing programs that are
equipped to both diagnose and promote entry into care for this
marginalized group.
The extremely low levels of access to HIV treatment and care in
the community reported by our participants may also be related to
the fact the majority were from rural areas, where there is less
infrastructure for diagnosing and treating individuals with HIV/
AIDS and greater stigmatization of drug use and HIV. Antiret-
roviral therapy may be subsidized in Malaysia but the actual
provision of treatment and care ultimately rests upon health care
providers. Efforts to increase access to treatment for people who
use drugs must engage the high levels of stigmatization of HIV and
drug use among Malaysian providers and actively address
misperceptions and discriminatory practices that compromise
treatment and care.
Conclusions
Detention and forced rehabilitation continues to be the
cornerstone of national drug policy in many Asian countries.
The profoundly negative impact of this punitive approach on
people who use drugs, their health and the health and well-being
of communities and society at large is more visible than ever before
and should be considered a health and human rights emergency.
Findings from this study bolster the ongoing closure of compulsory
drug detention and rehabilitation centers in Malaysia and
underscore the urgent need for evidence-based drug policies that
respect the rights of people who use drugs and seek to improve,
rather than undermine, their health.
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